Strs Ohio Prometheus Biosciences, Inc. Transaction History

Strs Ohio

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Aug 02, 2023	BUY	$103.46 - $126.29 $693,182 - $846,143	6,700 New	6,700 $719,000
Q1 2023 Apr 27, 2023	BUY	$103.46 - $126.29 $413,840 - $505,160	4,000 Added 148.15%	6,700 $719,000
Q4 2022 Jan 26, 2023	SELL	$36.06 - $117.21 $169,482 - $550,887	-4,700 Reduced 63.51%	2,700 $297,000
Q2 2022 Jul 25, 2022	BUY	$22.39 - $38.94 $8,956 - $15,576	400 Added 5.71%	7,400 $208,000
Q4 2021 Jan 24, 2022	BUY	$22.28 - $39.54 $98,032 - $173,976	4,400 Added 169.23%	7,000 $276,000
Q2 2021 Jul 26, 2021	BUY	$16.8 - $29.65 $43,680 - $77,090	2,600 New	2,600 $63,000

29.6K

Ticker RXDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,904,100
Description
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.